What does CUSIP 55279B202 represent in this 13F holders report?

CUSIP 55279B202 is the security identifier for MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value used to aggregate holder disclosures.

How many institutions held MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value in Q2 2015?

37 institutional investors reported MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value for Q2 2015. Use the holders table for investor-level position and value details.

MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)

CUSIP: 55279B202

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock, $0.00000002 par value
Shares outstanding: 29,545,622
Total 13F shares: 4,929,037
Share change: -3,049,905
Total reported value: $8,428,000
Put/Call ratio: 320%
Price per share: $1.71
Number of holders: 37
Value change: -$5,402,971
Number of buys: 20
Number of sells: 25

Security key

55279B202

Report period

Q2 2015

Institutions

Top holders

MEIP full security history Newer quarter: Q3 2015 Previous quarter: Q1 2015 Lite Strategy, Inc. SEC filings Lite Strategy, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 55279B202

Newer quarter: Q3 2015 Previous quarter: Q1 2015

Recent filing periods:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.9%	1,450,921	$2,597,000	—	31 Mar 2015	13F
FIRST MANHATTAN CO. LLC.	13F	Company	3.6%	1,050,000	$1,879,000	—	31 Mar 2015	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.7%	802,568	$1,437,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	2.7%	790,921	$1,415,000	—	31 Mar 2015	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	2.2%	649,580	$1,163,000	—	31 Mar 2015	13F
BVF INC/IL	13F	Company	2%	600,000	$1,074,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.5%	451,368	$808,000	—	31 Mar 2015	13F
SABBY MANAGEMENT, LLC	13F	Company	1%	296,491	$531,000	—	31 Mar 2015	13F
GROUP ONE TRADING LLC	13F	Company	0.78%	231,871	$415,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.75%	222,643	$399,000	—	31 Mar 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.59%	175,189	$314,000	—	31 Mar 2015	13F
Iguana Healthcare Management, LLC	13F	Company	0.51%	150,000	$269,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.46%	135,915	$243,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	127,753	$228,000	—	31 Mar 2015	13F
Endurant Capital Management LP	13F	Company	0.32%	95,438	$171,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.25%	72,820	$130,000	—	31 Mar 2015	13F
SIMPLEX TRADING, LLC	13F	Company	0.24%	70,249	$125,000	—	31 Mar 2015	13F
TFS CAPITAL LLC	13F	Company	0.24%	70,155	$126,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.23%	68,754	$123,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	0.23%	67,987	$122,000	—	31 Mar 2015	13F
GREAT POINT PARTNERS LLC	13F	Company	0.18%	52,254	$94,000	—	31 Mar 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.15%	43,356	$77,000	—	31 Mar 2015	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.15%	43,300	$78,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.14%	42,841	$77,000	—	31 Mar 2015	13F
Carnick & Kubik, LLC	13F	Company	0.1%	30,355	$54,000	—	31 Mar 2015	13F
Opus Point Partners Management, LLC	13F	Company	0.1%	30,000	$54,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.08%	22,487	$40,000	—	31 Mar 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	21,543	$39,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	20,370	$36,000	—	31 Mar 2015	13F
Visium Asset Management, LP	13F	Company	0.06%	16,411	$29,000	—	31 Mar 2015	13F
DENVER INVESTMENT ADVISORS LLC	13F	Company	0.05%	15,739	$28,000	—	31 Mar 2015	13F
Gilman Hill Asset Management, LLC	13F	Company	0.05%	15,399	$28,000	—	31 Mar 2015	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.04%	13,000	$23,000	—	31 Mar 2015	13F
STIFEL FINANCIAL CORP	13F	Company	0.04%	12,700	$23,000	—	31 Mar 2015	13F
CITIGROUP INC	13F	Company	0.02%	6,447	$12,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.02%	4,499	$8,000	—	31 Mar 2015	13F
BlackRock Japan Co. Ltd	13F	Company	0.01%	2,580	$5,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	2,000	$4,000	—	31 Mar 2015	13F
UBS Group AG	13F	Company	0%	1,207	$2,000	—	31 Mar 2015	13F
Creative Planning	13F	Company	0%	1,142	$2,000	—	31 Mar 2015	13F
SOUTH GEORGIA CAPITAL, LLC	13F	Company	0%	1,000	$2,000	—	31 Mar 2015	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	300	$1,000	—	31 Mar 2015	13F

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2015

As of 30 Jun 2015, MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,929,037 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, PANAGORA ASSET MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SABBY MANAGEMENT, LLC, Frigate Ventures LP, BlackRock Institutional Trust Company, N.A., Iguana Healthcare Management, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and GROUP ONE TRADING, L.P.. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

Q2 2015 holders

Holder diff

-4

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.